TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more
- PMID: 33085198
- DOI: 10.1002/ccd.29291
TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more
Comment on
-
Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.Catheter Cardiovasc Interv. 2020 Oct 1;96(4):947-955. doi: 10.1002/ccd.28834. Epub 2020 Mar 4. Catheter Cardiovasc Interv. 2020. PMID: 32129573 Free PMC article.
Similar articles
-
Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.Catheter Cardiovasc Interv. 2020 Jan;95(1):54-64. doi: 10.1002/ccd.28319. Epub 2019 Apr 29. Catheter Cardiovasc Interv. 2020. PMID: 31033152
-
Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.Circ Cardiovasc Interv. 2016 Jun;9(6):e003426. doi: 10.1161/CIRCINTERVENTIONS.115.003426. Circ Cardiovasc Interv. 2016. PMID: 27313280 Clinical Trial.
-
Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.Circ Cardiovasc Interv. 2016 Jun;9(6):e003665. doi: 10.1161/CIRCINTERVENTIONS.115.003665. Circ Cardiovasc Interv. 2016. PMID: 27296202 Clinical Trial.
-
Transcatheter Aortic Valve Replacement in Low-Risk Patients: A Meta-Analysis of Randomized Controlled Trials.Cardiovasc Revasc Med. 2020 Apr;21(4):461-466. doi: 10.1016/j.carrev.2019.08.008. Epub 2019 Aug 16. Cardiovasc Revasc Med. 2020. PMID: 31447314
-
Transcatheter Valve Replacement: Risk Levels and Contemporary Outcomes.Methodist Debakey Cardiovasc J. 2017 Jul-Sep;13(3):126-131. doi: 10.14797/mdcj-13-3-126. Methodist Debakey Cardiovasc J. 2017. PMID: 29743997 Free PMC article. Review.
Cited by
-
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease.Ann Med. 2023 Dec;55(1):2237521. doi: 10.1080/07853890.2023.2237521. Ann Med. 2023. PMID: 37493458 Free PMC article.
References
REFERENCES
-
- Khan MZ, Khan MU, Munir MB, Khan SU, Osman M, Balla S. Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease [published online ahead of print, 2020 Mar 4]. Catheter Cardiovasc Interv. 2020;96:947-955.
-
- Ndunda P, Srinivasan S, Vindhyal M, Muutu T, Vukas R, Fanari Z. Clinical outcomes of transcatheter vs surgical aortic valve replacement in patients with chronic liver disease: a systematic review and Metaanalysis. Ochsner J. 2019;19(3):241-247. https://doi.org/10.31486/toj.18.0178.
-
- Tarantini G, Nai Fovino L, D'Errigo P, et al. Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: results from the OBSERVANT study. Catheter Cardiovasc Interv. 2020;95(6):E186-E195. https://doi.org/10.1002/ccd.28447.
-
- Ueshima D, Barioli A, Nai Fovino L, et al. The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2020;95(5):993-1000. https://doi.org/10.1002/ccd.28335.
-
- Tarantini G, Masiero G, Nai Fovino L. Impact of a 10 rules protocol on COVID-19 hospital-related transmission: insights from Padua University Hospital, Italy. Circ Cardiovasc Interv. 2020;13(5):e009279. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009279.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources